Harmony Biosciences Holdings, Inc. · NASDAQ:HRMY

Harmony Biosciences Holdings, Inc. financial statements

Harmony Biosciences Holdings, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue868.5M714.7M582.0M437.9M305.4M159.7M6.00M0
Cost of revenue198.3M156.8M121.2M83.5M55.5M27.7M1.58M184.0K
Gross profit670.1M557.9M460.8M354.4M249.9M132.0M4.42M-184.0K
Research and development189.6M145.8M76.1M70.9M30.4M19.4M69.6M12.4M
Selling, general and administrative152.5M110.4M95.3M84.0M63.9M39.7M36.4M12.2M
Operating income208.5M190.8M192.0M120.2M87.5M17.0M-145.9M-41.4M
Depreciation and amortization25.3M267.0K514.0K419.0K416.0K394.0K395.0K184.0K
EBITDA233.8M191.1M192.5M120.6M87.9M17.4M-145.5M-41.3M
Interest expense14.6M17.5M23.8M18.8M24.2M28.6M7.36M0
Income before tax215.1M191.8M173.4M104.7M37.4M-36.9M-152.0M-39.9M
Income tax56.4M46.3M44.5M-76.8M2.83M14.9M6.07M1.54M
Net income158.7M145.5M128.9M181.5M34.6M-36.9M-152.0M-39.9M
Earnings per share, basic2.762.562.173.070.60-2.48-24.07-0.81
Earnings per share, diluted2.712.512.132.970.58-2.48-24.07

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents752.5M453.0M311.7M243.8M234.3M228.6M24.5M83.5M
Short-term investments22.8M14.2M41.8M79.3M0
Receivables96.8M83.0M74.1M54.7M34.8M22.2M4.25M0
Inventory5.36M7.20M5.36M4.30M4.43M3.82M1.09M0
Current assets907.0M579.3M451.1M400.3M284.4M262.9M31.5M86.7M
Property, plant and equipment1.26M371.0K573.0K820.0K938.0K1.33M1.58M
Total assets1.27B999.2M811.4M673.9M433.4M427.1M106.7M89.3M
Accounts payable17.7M13.7M17.7M3.79M1.00M2.56M6.36M1.46M
Current liabilities252.1M175.1M163.8M78.9M53.8M134.5M19.9M7.23M
Long-term debt143.7M163.0M178.6M189.6M190.0M194.3M97.9M
Total debt163.7M179.3M193.6M191.6M192.0M194.3M97.9M324.2M
Total liabilities401.4M340.0M344.5M271.0M246.9M329.9M118.3M7.75M
Shareholders' equity870.2M659.2M467.0M402.8M186.5M97.2M-422.9M81.5M
Shares outstanding57.7M57.1M56.8M59.6M58.8M56.9M7.79M49.2M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations348.2M219.8M219.4M144.5M98.6M-2.98M-75.4M-38.8M
Capital spending-310.0K-1.15M-312.0K-172.0K-298.0K-2.00K-149.0K-1.34M
Free cash flow347.9M218.7M219.1M144.3M98.3M-2.99M-75.6M-40.1M
Cash from investing-39.6M-67.5M-46.4M-141.8M-100.3M-2.00M-127.1M-1.34M
Cash from financing-9.05M-11.0M-105.6M6.84M7.42M209.2M143.8M21.6M
Dividends paid-5.05M-200.3M-143.8M
Share buybacks00-100.0M8.84M39.1M-167.0K-1.13M-3.20M
Change in cash299.5M141.3M67.4M9.47M5.68M204.2M-58.8M-18.5M